Dietary iron intake and anemia: food frequency questionnaire in patients with hereditary hemorrhagic telangiectasia
- PMID: 33081831
- PMCID: PMC7574540
- DOI: 10.1186/s13023-020-01554-x
Dietary iron intake and anemia: food frequency questionnaire in patients with hereditary hemorrhagic telangiectasia
Abstract
Background: Hereditary hemorrhagic telangiectasia (HHT) is a multisystemic inherited vascular disease characterized by a heterogeneous clinical presentation and prognosis. Dietary evaluation is relevant in HHT patients to provide adequate iron and nutrient intake. Additionally, different dietary items have been reported to precipitate epistaxis in this setting. Our primary aim was to investigate the dietary habits of HHT patients through a food-frequency questionnaire (FFQ) to evaluate the presence of precipitants and/or protective factors for epistaxis and the occurrence of possible dietary modifications. The secondary aims were to evaluate the nutritional intake of iron in HHT patients and the self-reported effect of iron treatments on epistaxis. From April 2018 to October 2018, a 138-item FFQ was provided to HHT patients followed up at the HHT Referral Center of Crema Maggiore Hospital. The relationship between food items and epistaxis was ascertained on a separate form. Daily iron intake was calculated to establish the mean iron content of food items reported in the FFQ.
Results: One hundred forty-nine questionnaires were evaluated [72 females, median age 54 years (12-76). Overall, 26 (18%) patients reported dietary items that improved epistaxis (mostly blueberries and red fruits, green vegetables and legumes), while 38 (26%) reported some dietary items that exacerbated epistaxis (spices, chocolate, alcohol, strawberries and ginger). Dietary modifications were reported in up to 58% of cases. In HHT patients, the mean daily iron intake was 8.46 ± 2.78 mg, and no differences were observed in the iron intake of patients reporting a diet modification and those who did not.
Conclusions: In the comprehensive management of HHT a healthy and balanced diet, with increased consumption of dietary items with a high iron content, should be encouraged.
Keywords: Epistaxis; Hereditary hemorrhagic telangiectasia; Iron deficiency; Iron supplementation; Nutrition.
Conflict of interest statement
The authors declare that they have no competing interests.
Similar articles
-
Lifestyle and dietary influences on nosebleed severity in hereditary hemorrhagic telangiectasia.Laryngoscope. 2013 May;123(5):1092-9. doi: 10.1002/lary.23893. Epub 2013 Feb 12. Laryngoscope. 2013. PMID: 23404156
-
7-day weighed food diaries suggest patients with hereditary hemorrhagic telangiectasia may spontaneously modify their diet to avoid nosebleed precipitants.Orphanet J Rare Dis. 2017 Mar 28;12(1):60. doi: 10.1186/s13023-017-0576-6. Orphanet J Rare Dis. 2017. PMID: 28347346 Free PMC article.
-
Hemorrhage-adjusted iron requirements, hematinics and hepcidin define hereditary hemorrhagic telangiectasia as a model of hemorrhagic iron deficiency.PLoS One. 2013 Oct 16;8(10):e76516. doi: 10.1371/journal.pone.0076516. eCollection 2013. PLoS One. 2013. PMID: 24146883 Free PMC article.
-
Endoscopic cryotherapy for the treatment of epistaxis due to hereditary hemorrhagic telangiectasia.J Craniofac Surg. 2014;25(2):e120-2. doi: 10.1097/SCS.0000000000000453. J Craniofac Surg. 2014. PMID: 24469376 Review.
-
Potential and emerging therapeutics for HHT.Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):724-727. doi: 10.1182/hematology.2024000675. Hematology Am Soc Hematol Educ Program. 2024. PMID: 39644056 Free PMC article. Review.
Cited by
-
Whole genome sequences discriminate hereditary hemorrhagic telangiectasia phenotypes by non-HHT deleterious DNA variation.Blood Adv. 2022 Jul 12;6(13):3956-3969. doi: 10.1182/bloodadvances.2022007136. Blood Adv. 2022. PMID: 35316832 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous